Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04918290 · ClinicalTrials.gov registry record · NA
Tegaderm Vs. Transpore for Eye Protection During Anesthesia
A NA study, sponsored by Tufts Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 165
- Enrollment target
NCT04918290 is a NA study that has completed, run by Tufts Medical Center. The registered enrollment target is 165 participants.
The verdict
NCT04918290, a NA study, has completed, sponsored by Tufts Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 165 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the rate of eyelid erythema after anesthesia with the use of TegadermTM vs. the Transpore®. Our null hypothesis is that the rate of erythema will be similar between the two groups given there is no evidence currently to suggest otherwise
Interventions
- DEVICE Tegaderm Eye Tape
- DEVICE Transpore Eye Tape
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 165 participants |
| Start Date | 2021-06-11 |
| Est. Completion | 2024-05-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04918290
The ClinicalTrials.gov registry entry for NCT04918290 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 165 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tufts Medical Center, which has 169 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Tegaderm Eye Tape is the first listed.
NCT04918290 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04918290 about?
NCT04918290 is a clinical study titled "Tegaderm Vs. Transpore for Eye Protection During Anesthesia". The purpose of this study is to compare the rate of eyelid erythema after anesthesia with the use of TegadermTM vs. the Transpore®. Our null hypothesis is that the rate of erythema will be similar between the two groups given there is no evidence currently to suggest otherwise
What is the current status of trial NCT04918290?
This trial is currently completed. It is a NA study. The enrollment target is 165 participants. The study started on 2021-06-11. Estimated completion is 2024-05-15.
What interventions are being tested in trial NCT04918290?
The interventions under investigation include: Tegaderm Eye Tape (DEVICE), Transpore Eye Tape (DEVICE).
Who is sponsoring clinical trial NCT04918290?
This trial is sponsored by Tufts Medical Center, which has 169 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.